Research Programs

Eight labs and programs within the Cardiovascular Research Center at Mayo Clinic conduct basic and clinical research to improve prevention and care of heart disease. These cardiovascular disease research programs translate scientific discoveries from the lab into leading-edge treatments and therapies for patients.

Cardiovascular Innovation Laboratory: The Cardiovascular Innovation Laboratory is a state-of-the-art translational research facility featuring a hybrid multimodality imaging suite. Learn more about the Cardiovascular Innovation Laboratory.

Circulatory Failure Program: The Circulatory Failure Program conducts both basic and clinical investigations aimed at improving the diagnosis and care of people with all forms of circulatory failure. Learn more about the Circulatory Failure Program.

Discovery Program: The Discovery Program is designed to advance the basic science of cardiovascular biology and medicine, laying the foundation for advances in therapeutics and biomarkers. Learn more about the Discovery Program.

Heart Rhythm Disease Program: The Heart Rhythm Disease Program focuses on atrial fibrillation, sudden arrhythmia death and research on cardiac devices. Learn more about the Heart Rhythm Disease Program.

Ischemic Heart Disease Program: The Ischemic Heart Disease Program focuses on research related to coronary artery disease and other diseases that cause myocardial ischemia. Learn more about the Ischemic Heart Disease Program.

Preventive Cardiology Program: The Preventive Cardiology Program is designed to understand and educate about ways to prevent heart disease and encourage preventive care. Learn more about the Preventive Cardiology Program.

Structural Heart Disease Program: The Structural Heart Disease Program is designed to maintain a collaborative research environment for structural heart disease investigators at Mayo Clinic. Learn more about the Structural Heart Disease Program.

Vascular Disease Program: The Vascular Disease Program is designed to understand, treat and potentially cure carotid artery disease, peripheral artery disease, venous thromboembolism and other diseases. Learn more about the Vascular Disease Program.